Infectious Disease Molecular Diagnostics Market Size and Share Forecast Outlook 2025 to 2035

The Infectious Disease Molecular Diagnostics Market is estimated to be valued at USD 40.1 billion in 2025 and is projected to reach USD 60.5 billion by 2035, registering a compound annual growth rate (CAGR) of 4.2% over the forecast period.

Quick Stats for Infectious Disease Molecular Diagnostics Market

  • Infectious Disease Molecular Diagnostics Market Industry Value (2025): USD 40.1 billion
  • Infectious Disease Molecular Diagnostics Market Forecast Value (2035): USD 60.5 billion
  • Infectious Disease Molecular Diagnostics Market Forecast CAGR: 4.2%
  • Leading Segment in Infectious Disease Molecular Diagnostics Market in 2025: Polymerase chain reaction (PCR) (48.6%)
  • Key Growth Region in Infectious Disease Molecular Diagnostics Market: North America, Asia-Pacific, Europe
  • Top Key Players in Infectious Disease Molecular Diagnostics Market: BD, BioMérieux SA, Bio-Rad Laboratories Inc, Abbott, Agilent Technologies, Inc., Danaher, Hologic Inc, Illumina Inc, Johnson & Johnson Services Inc, Grifols S.A., QIAGEN, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG

Infectious Disease Molecular Diagnostics Market

Rationale for Segmental Growth in the Alginic Acid Market

Market Overview

The alginic acid market is undergoing consistent growth, propelled by rising demand from food processing, pharmaceutical formulations, and cosmetic applications. A growing focus on natural and sustainable ingredients in manufacturing processes has positioned alginic acid as a preferred biopolymer across industries.

The market is further supported by its diverse functional benefits, including water retention, gelling, and stabilizing properties, which make it indispensable in high-performance formulations. Increased regulatory acceptance of alginates as safe additives and the push towards cleaner labeling in food and personal care products have reinforced their adoption.

Ongoing innovation in extraction technologies and the utilization of algae as a renewable resource are paving the way for cost-effective production and expanded applications, ensuring sustained market expansion in the coming years.

Segmental Analysis

The market is segmented by Technology, Product Type, End Use, and Application and region. By Technology, the market is divided into Polymerase chain reaction (PCR), In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, and Others. In terms of Product Type, the market is classified into Instruments, Reagents, and Services. Based on End Use, the market is segmented into Hospitals, Clinics, Diagnostics Laboratories, and Research Institutes. By Application, the market is divided into Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, HPV, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, and Other Infectious Diseases. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

The market is segmented by Technology, Product Type, End Use, and Application and region. By Technology, the market is divided into Polymerase chain reaction (PCR), In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, and Others. In terms of Product Type, the market is classified into Instruments, Reagents, and Services. Based on End Use, the market is segmented into Hospitals, Clinics, Diagnostics Laboratories, and Research Institutes. By Application, the market is divided into Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, HPV, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, and Other Infectious Diseases. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Sodium Alginate Salts Segment

When segmented by salts, sodium alginate is expected to command 27.5% of the market revenue in 2025, marking it as the leading subsegment in this category. This leadership has been driven by its superior solubility, ease of incorporation into formulations, and versatility in a wide range of applications.

Its ability to form stable gels and maintain viscosity under varying conditions has made it highly sought after in both food and pharmaceutical sectors. Manufacturers have prioritized sodium alginate due to its consistent performance, cost-effectiveness, and regulatory acceptance, which have collectively strengthened its position.

The segment’s prominence has also been enhanced by its adaptability to evolving consumer preferences for plant-derived and sustainable ingredients, reinforcing its market share.

Insights into the Food Industry End User Industry Segment

Segmented by end user industry, the food industry is projected to hold 33.0% of the market revenue in 2025, positioning it as the most prominent sector. This dominance has been shaped by the industry’s increasing reliance on alginic acid and its derivatives to deliver desirable textures, stabilize emulsions, and improve shelf life of processed foods.

As consumer demand for clean label and natural additives has intensified, the food sector has responded by integrating alginates into bakery, dairy, and confectionery products. Enhanced production efficiency and compliance with food safety standards have further encouraged widespread use.

The segment’s leadership has also been supported by product differentiation strategies where alginates contribute to premium quality and innovation, securing their role in modern food formulations.

Insights into the Thickening Agent Functionality Segment

When analyzed by functionality, thickening agents are forecast to account for 29.0% of the market revenue in 2025, establishing themselves as the dominant functional category. This preeminence has been underpinned by the growing need for consistent texture and viscosity in a wide array of end products.

Alginic acid’s natural origin and high efficiency in creating uniform, stable thickness without altering taste or color have solidified its appeal. The demand for thickeners in both edible and topical applications has expanded, with manufacturers leveraging its rheological properties to meet performance and regulatory requirements.

The functionality’s leading share has also been reinforced by the ability to deliver cost savings through lower dosages and its compatibility with other ingredients, securing its position as an indispensable component in formulation strategies.

2017 to 2021 Global Infectious Disease Molecular Diagnostics Sales Outlook Compared to Forecast from 2022 to 2032

The global market for the Infectious Disease Molecular Diagnostics Market expanded at a CAGR of 3.8% over the last four years (2020 to 2024). Future Market Insights’ analysis reveals that in 2025 revenue through the market is estimated at USD 40.1 billion. With an absolute dollar opportunity of USD 18 billion from 2025 to 2035, the market is projected to reach a valuation of USD 60.5 billion by 2035.

The USA will continue to be the largest consumer of the Infectious Disease Molecular Diagnostics Market throughout the analysis period accounting for over USD 5.8 billion absolute dollar opportunity in the coming 10-year period

Key Growth Drivers Influencing the Infectious Disease Molecular Diagnostics Industry

Global outbreaks of deadly infectious diseases caused by pathogenic microorganisms have threatened public health worldwide and significantly motivated researchers to develop rapid and accurate detection methods for pathogens. Culture-based techniques are considered gold standards for pathogen detection globally.

However, the long result time associated with these techniques due to overnight culturing and limited pathogen isolation has slowed their demand to a certain extent. Over the past several years, innovations in molecular diagnostic technology and their use have fundamentally altered the ability to handle infectious diseases. It provides quicker and more reliable results at 30% less cost to the customers.

Although still in its infancy, pharmacogenomics has the potential to grow into a rich industry as demand for tailored medication rises. As the driving force behind the transition to personalized medicine, many pharmaceutical companies are assessing revenue models based on molecular diagnostics for pharmacogenomics testing.

Major Challenges Restraining the Infectious Disease Molecular Diagnostics Industry

One of the key factors limiting the growth of the infectious disease molecular diagnostics market is inadequate reimbursements. The hurdles to getting Medicare insurance to pay for diagnostic tests are a significant concern for diagnostic organizations.

In 2020, Medicare in the USA tightened constraints on I.V.D. diagnostic claims, which affected molecular diagnostic tests in particular. These molecular pathology tests might be billed using unlisted medical codes rather than the American Medical Association's Current Procedural Terminology (CPT) numbers. Medicare Administrative Contractors (MACs) set the allowable cost amount for the billing locality in these cases.

The entirety of the clinical lab will gradually be expected to execute molecular diagnostics testing on a regular basis. Venture capitalists, who formerly preferred not to make investments in this area, will progressively grow more enthusiastic about investing in molecular diagnostic businesses as the field of molecular diagnostics progresses.

Top Regions Leading the Infectious Disease Molecular Diagnostics Landscape

In what ways does the Infectious Disease Molecular Diagnostics Market in North America have a bright future?

The American Cancer Society estimates that there will be 1.7 million new instances of cancer in the US this year and more than 606 thousand cancer-related deaths. Therefore, it is predicted that over the forecast period, the demand for molecular diagnostics would expand due to the rising incidence of cancer and increased public awareness of the importance of early cancer detection.

The development and global distribution agreement for molecular testing in Mexico to find new sexually-transmitted infections were announced by Becton Dickinson and Euroclone in February 2020. The market is projected to expand in the future due to rising diseases and innovation in North America.

Top Countries Advancing Infectious Disease Molecular Diagnostics Adoption

Infectious Disease Molecular Diagnostics Market Cagr Analysis By Country

United States Infectious Disease Molecular Diagnostics Market Analysis

Infectious Disease Molecular Diagnostics Market Country Value Analysis

The USA will account for over USD 60.5 billion of the global market by 2035. 6 out of 10 of America's adults have a chronic disease, and 4 out of 10 people have two or more diseases. , as of January 2024, according to a report made public by the National Center for Chronic Disease Prevention and Health Promotion.

The US FDA had received emergency use authorization requests from Becton, Dickinson, and Company, and BioGX Inc. for novel diagnostic tests, the two businesses announced in March 2024.

UK Infectious Disease Molecular Diagnostics Market Analysis

The market in the UK is expected to reach USD 38.5 billion, growing from USD 1.5 billion in 2024. The market in the country is projected to expand at a CAGR of 3.5% from 2025 to 2035, and prosper with an absolute dollar opportunity of USD 644 million.

Japan Infectious Disease Molecular Diagnostics Market Analysis

Infectious Disease Molecular Diagnostics Market Japan Market Share Analysis By Technology

The market in Japan is expected to gross an absolute dollar opportunity of USD 40.1 million from 2025 to 2035. During this period, the market is projected to register a CAGR of 5.9% to reach a market size of USD 2.3 billion by 2035.

South Korea Infectious Disease Molecular Diagnostics Market Analysis

Infectious Disease Molecular Diagnostics Market South Korea Market Share Analysis By Product Type

The market in South Korea is expected to gross an absolute dollar opportunity of USD 400 million from 2025 to 2035. The market is likely to reach a valuation of USD 1.1 billion by 2035.

Infectious Disease Molecular Diagnostics Industry Analysis by Technology, Application, and End User

Why Polymerase Chain Reaction (PCR) segment dominates the Infectious Disease Molecular Diagnostics Technology Revenue?

The Polymerase Chain Reaction (PCR) segment account for over 30% of the technology category of the global Infectious Disease Molecular Diagnostics Market. The market growth from 2020 to 2024 was estimated at 4.4% CAGR. A qualitative outcome of a PCR investigation may be required for the detection of genetic polymorphisms, inherited disorders, somatic mutations, including cancer, and the presence of viral or microbial infections.

Quantitative PCR is increasingly needed, for instance, to assess a pathogen's titer, the quantity of infected or altered cells in a tissue, and the concentration of particular mRNAs.

PCR has several uses in medicine, including tissue typing for organ and tissue transplants. Commercially, HLA DQa locus analysis kits are currently readily available. The application of PCR for forensic purposes is associated with this application. The PCR can use this area, in particular, to take advantage of its extreme sensitivity.

Leading Suppliers of Infectious Disease Molecular Diagnostics Solutions

At present, many diagnostics firms that were under-represented in this area have sought partners or acquisitions to gain exposure, reflecting the growing interest in personalized medicine.

The key companies operating in the market include F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Abbott Laboratories, bioMérieux SA, QIAGEN N.V., Myriad Genetics, Inc., Siemens Healthineers AG, Danaher Corporation, Illumina, Inc., Becton Dickinson and Company, Grifols, S.A., Quidel Corporation, Agilent Technologies, Inc., DiaSorin S.p.a. (Italy), Exact Sciences Corporation, Genetic Signatures, MDx Health, Biocartis NV, TBG Diagnostics Limited, HTG Molecular Diagnostics, Inc., Vela Diagnostics, Amoy Diagnostics Co., Ltd., ELITechGroup, Molbio Diagnostics Pvt. Ltd., Savyon Diagnostics, Abacus Diagnostica Oy, and geneOmbio Technologies Pvt. Ltd.

Some of the recent developments by key providers of Infectious Disease Molecular Diagnostics are as follows:

  • In September 2024, F. Hoffmann-La Roche Ltd. announced the acquisition of TIB Molbiol to increase the breadth of infectious illness assays in its PCR test line.
  • In June 2024 Verogen and QIAGEN N.V. collaborated to increase the range of NGS technologies available.
  • In June 2024, Mobidiag Oy, a provider of acute care molecular diagnostic testing, was purchased by Hologic, Inc. The product offering for molecular diagnostics at Hologic will be boosted by this acquisition.
  • In November 2024, an additional FDA approval was given to Hologic, Inc. for the AptimaHIV-1 Quant Dx Assay's use in assisting with HIV infection diagnosis.

Similarly, recent developments related to companies manufacturing infectious disease molecular diagnostics kits have been tracked by the team at Future Market Insights, which is available in the full report.

Top Investment Segments in Infectious Disease Molecular Diagnostics Industry

By Technology:

  • Polymerase chain reaction (PCR)
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Others

By Product Type:

  • Instruments
  • Reagents
  • Services

By End Use:

  • Hospitals
  • Clinics
  • Diagnostics Laboratories
  • Research Institutes

By Application:

  • Respiratory Diseases
  • Tuberculosis
  • Meningitis
  • Gastrointestinal Tract Infections
  • HPV
  • Sexually Transmitted Infections
  • Sepsis
  • Drug Resistance Diseases
  • Other Infectious Diseases

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Content

  1. Executive Summary
    • Global Market Outlook
    • Demand-side Trends
    • Supply-side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. Global Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
    • Historical Market Size Value (USD Million) Analysis, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
      • Y-o-Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. Global Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
  6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Technology
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Technology , 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Technology , 2025 to 2035
      • Polymerase chain reaction (PCR)
      • In Situ Hybridization
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Chips and Microarrays
      • Mass Spectrometry
      • Sequencing
      • Others
    • Y-o-Y Growth Trend Analysis By Technology , 2020 to 2024
    • Absolute $ Opportunity Analysis By Technology , 2025 to 2035
  7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Product Type
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Product Type, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Product Type, 2025 to 2035
      • Instruments
      • Reagents
      • Services
    • Y-o-Y Growth Trend Analysis By Product Type, 2020 to 2024
    • Absolute $ Opportunity Analysis By Product Type, 2025 to 2035
  8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End Use
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End Use, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End Use, 2025 to 2035
      • Hospitals
      • Clinics
      • Diagnostics Laboratories
      • Research Institutes
    • Y-o-Y Growth Trend Analysis By End Use, 2020 to 2024
    • Absolute $ Opportunity Analysis By End Use, 2025 to 2035
  9. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Application
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Application, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2025 to 2035
      • Respiratory Diseases
      • Tuberculosis
      • Meningitis
      • Gastrointestinal Tract Infections
      • HPV
      • Sexually Transmitted Infections
      • Sepsis
      • Drug Resistance Diseases
      • Other Infectious Diseases
    • Y-o-Y Growth Trend Analysis By Application, 2020 to 2024
    • Absolute $ Opportunity Analysis By Application, 2025 to 2035
  10. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2024
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East & Africa
    • Market Attractiveness Analysis By Region
  11. North America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • USA
        • Canada
        • Mexico
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Market Attractiveness Analysis
      • By Country
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Key Takeaways
  12. Latin America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Brazil
        • Chile
        • Rest of Latin America
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Market Attractiveness Analysis
      • By Country
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Key Takeaways
  13. Western Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Germany
        • UK
        • Italy
        • Spain
        • France
        • Nordic
        • BENELUX
        • Rest of Western Europe
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Market Attractiveness Analysis
      • By Country
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Key Takeaways
  14. Eastern Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Russia
        • Poland
        • Hungary
        • Balkan & Baltic
        • Rest of Eastern Europe
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Market Attractiveness Analysis
      • By Country
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Key Takeaways
  15. East Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • China
        • Japan
        • South Korea
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Market Attractiveness Analysis
      • By Country
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Key Takeaways
  16. South Asia and Pacific Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of South Asia and Pacific
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Market Attractiveness Analysis
      • By Country
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Key Takeaways
  17. Middle East & Africa Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Kingdom of Saudi Arabia
        • Other GCC Countries
        • Turkiye
        • South Africa
        • Other African Union
        • Rest of Middle East & Africa
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Market Attractiveness Analysis
      • By Country
      • By Technology
      • By Product Type
      • By End Use
      • By Application
    • Key Takeaways
  18. Key Countries Market Analysis
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • France
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • India
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Australia & New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • China
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Russia
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Kingdom of Saudi Arabia
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • Turkiye
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Technology
        • By Product Type
        • By End Use
        • By Application
  19. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Technology
      • By Product Type
      • By End Use
      • By Application
  20. Competition Analysis
    • Competition Deep Dive
      • BD
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • BioMérieux SA
      • Bio-Rad Laboratories Inc
      • Abbott
      • Agilent Technologies, Inc.
      • Danaher
      • Hologic Inc
      • Illumina Inc
      • Johnson & Johnson Services Inc
      • Grifols S.A.
      • QIAGEN
      • F. Hoffmann-La Roche Ltd
      • Siemens Healthineers AG
  21. Assumptions & Acronyms Used
  22. Research Methodology

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2020-2035
  • Table 2: North America Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 3: Latin America Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 4: Western Europe Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 5: Eastern Europe Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 6: East Asia Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 7: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 8: Middle East & Africa Market Value (USD Million) Forecast by Country, 2020-2035

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2020-2035
  • Figure 3: Global Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
  • Figure 4: Global Market Y-o-Y Growth Comparison by Region, 2025-2035
  • Figure 5: Global Market Attractiveness Analysis by Region
  • Figure 6: North America Market Incremental $ Opportunity, 2025-2035
  • Figure 7: Latin America Market Incremental $ Opportunity, 2025-2035
  • Figure 8: Western Europe Market Incremental $ Opportunity, 2025-2035
  • Figure 9: Eastern Europe Market Incremental $ Opportunity, 2025-2035
  • Figure 10: East Asia Market Incremental $ Opportunity, 2025-2035
  • Figure 11: South Asia and Pacific Market Incremental $ Opportunity, 2025-2035
  • Figure 12: Middle East & Africa Market Incremental $ Opportunity, 2025-2035
  • Figure 13: North America Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 14: Latin America Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 15: Western Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 16: Eastern Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 17: East Asia Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 18: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 19: Middle East & Africa Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 20: Global Market - Tier Structure Analysis
  • Figure 21: Global Market - Company Share Analysis

Frequently Asked Questions

How big is the infectious disease molecular diagnostics market in 2025?

The global infectious disease molecular diagnostics market is estimated to be valued at USD 40.1 billion in 2025.

What will be the market size for the infectious disease molecular diagnostics market in 2035?

It is projected to reach USD 60.5 billion by 2035.

How much will be the CAGR of the infectious disease molecular diagnostics market between 2025 and 2035?

The market is expected to grow at a 4.2% CAGR between 2025 and 2035.

What are the key product types in the infectious disease molecular diagnostics market?

The key product types are polymerase chain reaction (pcr), in situ hybridization, isothermal nucleic acid amplification technology (inaat), chips and microarrays, mass spectrometry, sequencing and others.

Which instruments segment is expected to dominate the infectious disease molecular diagnostics market in 2025?

instruments segment is expected to dominate with a 42.7% industry share in 2025.

Explore Similar Insights

Future Market Insights

Infectious Disease Molecular Diagnostics Market